Discover
KTTA
Pasithea Therapeutics Corp.
0.52
2 x 0.35
2 x 0.65
bid
ask
+
0.02
3.36%
2 @ 07:57 PM
0.49 -0.03 (5.86%)
| Ytd | -59.40% | |
| 1y | -27.26% |
0.49
day range
0.55
0.29
52 week range
1.47
| Open | 0.53 | Prev Close | 0.51 | Low | 0.49 | High | 0.55 | Mkt Cap | 17.50M |
| Vol | 483.38K | Avg Vol | 699.20K | EPS | -1.35 | P/E | N/A | Forward P/E | -3.75 |
| Beta | 0.82 | Short Ratio | 0.32 | Inst. Own | 2.87% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-16 | 50-d Avg | 0.50 | 200-d Avg | 0.73 | 1yr Est | 2.00 |
| Income Statement | |||
| Operating Expenses | 5.71M | ||
| Research and Development Expense | 3.69M | ||
| Selling, General and Administrative Expense | 2.03M | ||
| Operating Income | -5.71M | ||
| Net Income | -5.27M | ||
| Net Income Common Stock | -5.27M | ||
| Net Income Common Stock (USD) | -5.27M | ||
| Consolidated Income | -5.27M | ||
| Earnings per Basic Share | -0.16 | ||
| Earnings per Basic Share (USD) | -0.16 | ||
| Earnings per Diluted Share | -0.16 | ||
| Earning Before Interest & Taxes (EBIT) | -5.27M | ||
| Earning Before Interest & Taxes (USD) | -5.27M | ||
| Weighted Average Shares | 32.10M | ||
| Weighted Average Shares Diluted | 32.10M | ||
| Balance Sheet | |||
| Cash and Equivalents | 45.77M | ||
| Cash and Equivalents (USD) | 45.77M | ||
| Current Assets | 48.24M | ||
| Total Assets | 51.71M | ||
| Current Liabilities | 1.84M | ||
| Total Liabilities | 1.87M | ||
| Accumulated Retained Earnings (Deficit) | -78.15M | ||
| Accumulated Other Comprehensive Income | 9.57K | ||
| Shareholders Equity | 49.84M | ||
| Shareholders Equity (USD) | 49.84M | ||
| Assets Non-Current | 3.47M | ||
| Goodwill and Intangible Assets | 3.47M | ||
| Liabilities Non-Current | 32.34K | ||
| Trade and Non-Trade Payables | 1.84M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 157.54K | ||
| Net Cash Flow from Financing | 8.48K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -4.74M | ||
| Issuance (Purchase) of Equity Shares | 8.48K | ||
| Net Cash Flow from Operations | -4.71M | ||
| Effect of Exchange Rate Changes on Cash | -37.33K | ||
| Share Based Compensation | 329.94K | ||